Abstract
LMWH is recommended by major consensus guidelines for both initial
and long-term #anticoagulation in cancer-associated thrombosis.
With improvements in imaging technology and extended survival duration
of #cancer patients, more unique challenges are encountering.
These include optimal duration of anticoagulant #therapy, management of
incidental VTE, identifying #biomarkers that can predict recurrent
VTE, treatment of recurrent VTE after initial therapy, the treatment of
patients with concurrent bleeding or those at a high risk of bleeding,
management of VTE in #intracranialmalignancies and the limitations of
the novel direct oral anticoagulants.
For more articles on Biomedical open access journals please click here: https://biomedres.us/
For more Biomedical Open Access Articles on BJSTR
Cancer Associated #Thrombosis: Still many unanswered Questions by Nahla AM Hamed in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.